Cafepharma Today

November 7 2024 - Moderna posts surprise profit
Moderna posts surprise profit
With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Sarepta pulls plug on Duchenne exon-skipping drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pfizer To Abandon Heart Drugs: Report
The Street.com
Tuesday, September 30, 2008 - 8:15am
tags:
A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
Yahoo
Tuesday, September 30, 2008 - 8:14am
tags:
Could Market Turmoil Foil Roche’s Bid for Genentech?
WSJ Online
Tuesday, September 30, 2008 - 8:14am
tags:
Under Sweeping Settlement, Cephalon Will Disclose Doctor Payments
WSJ Online
Tuesday, September 30, 2008 - 8:13am
tags:
Sanofi, Daiichi Delay Japan's First Imported Vaccine
Bloomberg
Tuesday, September 30, 2008 - 8:12am
tags:
Eli Lilly shares fall on uncertainty over FDA review of potential blockbuster blood-thinner
Yahoo/AP
Monday, September 29, 2008 - 12:20pm
tags:
4-Star Stocks Poised to Pop: Pfizer
Motley Fool
Monday, September 29, 2008 - 12:20pm
tags:
Osiris On Prochymal Commercialization
Cafepharma Detailpiece
Monday, September 29, 2008 - 12:19pm
tags:
Cephalon to pay $425 million to settle claims of marketing drugs for alternate uses
Yahoo/AP
Monday, September 29, 2008 - 11:17am
tags:
The Waiting Game Continues For Lilly & ImClone
CNBC
Monday, September 29, 2008 - 11:14am
tags:
Drug stocks slide as global markets swoon
Marketwatch
Monday, September 29, 2008 - 10:29am
tags:
Eli Lilly says Alimta gets regulatory approval as primary treatment for lung cancer
Yahoo/AP
Monday, September 29, 2008 - 10:29am
tags:
Regeneron Pharmaceuticals (REGN) Reports Results from Phase 2 Study of VEGF Trap-Eye
Street Insider
Monday, September 29, 2008 - 9:45am
tags:
ImClone says second acquirer set to bid or withdraw
Yahoo/Reuters
Monday, September 29, 2008 - 9:43am
tags:
ImClone: Second bidder has until Oct. 1 to make offer
Marketwatch
Monday, September 29, 2008 - 9:42am
tags:
Break Up To Make Up: Pfizer, Asset Sales & Layoffs
Pharmalot
Monday, September 29, 2008 - 9:40am
tags:
ImClone to Reveal Mystery Suitor?
Seeking Alpha
Monday, September 29, 2008 - 9:36am
tags:
ImClone Keeps Courting Secret Admirer
WSJ Online
Monday, September 29, 2008 - 9:04am
tags:
Predictions on Imclone's Suitors
Seeking Alpha
Monday, September 29, 2008 - 9:03am
tags:
Lilly Sinks After Hours on Effient Delay
Seeking Alpha
Monday, September 29, 2008 - 9:02am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

The Choice Made
In the Pipeline
Just How Lipophilic Is That Huge Thing?
In the Pipeline
Down in the Mantle
In the Pipeline
Transparency Shocker: Biosimilars Are Getting Cheaper—But Hospitals and Insurers Can Make Them Expensive
Drug Channels
How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Anti-Bredt Olefins: Never Say Never!
In the Pipeline
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Morgantown, WV
Morgantown, West Virginia, 26501
Otsuka
Territory Manager, Medical Dermatology - Omaha, NE
Julian, Nebraska, 68379
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement- Tampa
Tampa, Florida, 33646
Otsuka
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia, 20022
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon, 97403
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia, 30383
Otsuka
Pharmaceutical Sales Customer Engagement- Columbus, OH
Columbus, Ohio, 43224
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Baltimore S, MD
Baltimore, Maryland, 21276
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Allentown, PA
Allentown, Pennsylvania, 18103
Otsuka
Territory Manager, Medical Dermatology - Sacramento, CA
Clarksburg, California, 95612
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information